drugset / Trial / NCT01933217

Methylphenidate for Attention Problems After Pediatric TBI

NCT01933217 ↗

Phase 4 Completed 26 enrolled Children's Hospital Medical Center, Cincinnati
RandomizedCrossoverQuadruple-blindTreatment

Summary

Traumatic Brain Injury (TBI) - methylphenidate treatment

Timeline

Start
2013-11
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 18 mg —
Subject Methylphenidate Small molecule 27 mg —
Subject Methylphenidate Small molecule 36 mg —
Subject Methylphenidate Small molecule 54 mg —